Follow us on LinkedIn - https://www.linkedin.com/company/fatty-liver-alliance/
Follow us on LinkedIn - https://www.linkedin.com/company/fatty-liver-alliance/
Signed in as:
filler@godaddy.com

The Fatty Liver Alliance (FLA) is a global patient-led organization dedicated to education as the front line of prevention, early identification, and action in liver and metabolic disease.
FLA translates rapidly evolving liver and metabolic science into practical, accessible education for patients, communities, and healthcare professionals. We focus on meeting people where they are, whether that is at international medical conferences, in primary care practices, or directly within communities at risk.
Our work spans the full education continuum. We share timely insights from leading liver and metabolic conferences through FLA Live. We deliver community-based education and awareness through Your Liver, Your Health events. We provide walk-in, non-clinical education using non-invasive tools through the Liver Health Awareness Centre. And we equip frontline clinicians through professional education, including our annual Primary Care Summit.
Across all programs, FLA’s role is consistent: to make complex science understandable, relevant, and actionable, and to help individuals and providers recognize liver risk earlier, before irreversible disease develops.
FLA does not diagnose or treat disease. We educate, contextualize risk, and encourage informed follow-up within the healthcare system. Our work is grounded in lived experience, real-world data, and collaboration with researchers, clinicians, and global liver organizations.
By advancing education across global, local, and individual levels, the Fatty Liver Alliance works to close the gap between knowledge and action in liver and metabolic health.

Our Mission:
We raise awareness about the risks, causes and complications of fatty liver disease and help those already diagnosed with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) by advocating for access to approved treatments and care.
Our Vision:
To live in a country where fatty liver disease is preve
Our Mission:
We raise awareness about the risks, causes and complications of fatty liver disease and help those already diagnosed with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) by advocating for access to approved treatments and care.
Our Vision:
To live in a country where fatty liver disease is prevented and all patients who need treatment are able to receive the best available tailored care.
Our Purpose:
To educate the public about the risks, causes, effects and complications of, and treatments for, non-alcoholic fatty liver disease through virtual and in-person presentations, conferences, meetings, and webinars, and by collecting and disseminating information on that topic.
To promote health by conducting or funding research into the causes, controls and cure of non-alcoholic fatty liver disease and by making the results available to the public.

Aiming to establish Fatty Liver Alliance as the trusted voice in Fatty Liver Disease, we are intensifying our educational efforts, targeting medical professionals, patients, and the broader community. Initiatives such as community events, social media posts, fireside chats with liver experts and the annual Primary Care Summit play pivotal
Aiming to establish Fatty Liver Alliance as the trusted voice in Fatty Liver Disease, we are intensifying our educational efforts, targeting medical professionals, patients, and the broader community. Initiatives such as community events, social media posts, fireside chats with liver experts and the annual Primary Care Summit play pivotal roles in this endeavor. This pillar is essential for driving changes at the grassroots level and establishing FLA as a thought leader.

FLA is reinforcing its global presence and domestic influence. By actively participating in global liver and metabolic disease conferences and representing Canada in international liver health discussions, we're striving to be Canada's go-to authority for MASLD/MASH. This pillar is also key to becoming a trusted partner in Canada for all
FLA is reinforcing its global presence and domestic influence. By actively participating in global liver and metabolic disease conferences and representing Canada in international liver health discussions, we're striving to be Canada's go-to authority for MASLD/MASH. This pillar is also key to becoming a trusted partner in Canada for all MASLD/MASH activities, solidifying FLA's role as "the voice" of these conditions nationally.

Acknowledging the significance of shaping public policy, we consistently engage with governmental bodies to advocate for legislative modifications, ensuring better care and services for MASLD/MASH patients. This facet underscores FLA's role in guiding public policy and healthcare benchmarks. Through ongoing dialogues with government agenc
Acknowledging the significance of shaping public policy, we consistently engage with governmental bodies to advocate for legislative modifications, ensuring better care and services for MASLD/MASH patients. This facet underscores FLA's role in guiding public policy and healthcare benchmarks. Through ongoing dialogues with government agencies, involvement in advisory panels, and public statements, FLA seeks to influence legislative shifts. This contributes to the long-term enhancement of treatment access and services for MASLD/MASH patients. This pillar ensures that all other pillars can be effectively executed and that the organization remains financially healthy and impactful.

The robust financial health of FLA is imperative for realizing our goals. With an aim of a 20% year-over-year growth, we are diversifying our funding streams which include corporate sponsorships, donations, and income-generating events.
Your support and contributions will enable our not-for-profit to meet our goals and your generous donations will fund our mission. We do not yet have CRA charity status, so we cannot issue a tax receipt for donations given.


On International NASH Day 2023, Michael Betel of the Fatty Liver Alliance, addressed NAFLD and NASH, their prevalence and impact. Discover solutions including medical education, patient awareness, and advocacy. Learn about the Alliance's future goals.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.